Abstract
Several benzimidazole derivatives have been tested in vitro for their ability to inhibit human placental aromatase activity. The results show that five out of the six compounds tested are more active in the inhibition of aromatase activity than aminoglutethimide (AG), which we chose as the reference compound and which, as an aromatase inhibitor, is currently being used in the treatment of metastatic breast cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
